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Purpose: To evaluate the effect of asphericity and blue light filter (BLF) of three different
intraocular lenses (IOLs) on the visual performance, second- and third-order aberrations
(defocus, coma, trefoil), and contrast sensitivity after uneventful cataract surgery.
Methods: One hundred and twenty eyes of 60 patients with clinically significant cataract
were randomly assigned to receive one of the three IOL types: Bioline Yellow Accurate
(aspheric, with BLF, i-medical, Germany), BioAcryl 60125 (spherical, without BLF, Biotech,
France), and H65C/N (aspheric, without BLF, PhysIOL, Belgium). Each IOL was implanted in 40
eyes. Complete ophthalmologic examination, functional acuity contrast testing and wavefront
analysis were performed 60 days postoperatively.
Results: The mean postoperative best-corrected visual acuity (BCVA) was 0.95 ± 0.08, not
differing statistically among the IOL groups (P = 0.83). Mean defocus and coma values did
not yield any statistically significant difference through the IOL groups varying from –0.784 to
–0.614 μm and 0.129 to 0.198 μm (P = 0.79 and 0.34, respectively). Bioline Yellow Accurate
IOL presented less trefoil aberrations, 0.108 ± 0.05 μm, compared to the other two IOL types
(BioAcryl [0.206 ± 0.19 μm] and Physiol [0.193 ± 0.17 μm], P < 0.05). Contrast sensitivity
values did not differ among the groups under all lighting conditions. Bioline Yellow IOL
showed a statistically higher loss of contrast sensitivity (between mesopic and mesopic with
glare conditions) compared to the BioAcryl and PhysIOL in 12 and 3 cpd spatial frequencies,
respectively (P < 0.05).
Conclusion: Bioline Yellow IOL indicated lower contrast sensitivity under mesopic conditions
when glare was applied but resulted in less trefoil aberrations after uneventful cataract surgery.
No further differences were noted in postoperative visual performance among three IOL
groups.
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Modern cataract surgery has recently evolved
into a refractive procedure aimed at improving
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visual quality in addition to increasing the visual
acuity. Therefore, it is routinely combined with the
implantation of intraocular lenses (IOLs) of various
materials and designs.
Since the initial introduction of IOLs, there has
been great debate over the importance of light
filtration.[1–5] Ultraviolet (UV) light-filtering lenses
have been the dominant IOLs used in the modern
era since growing evidence indicated that UV light
could result in photic retinopathy and other retinal
pathologies.[6] There has recently though been
support for increasing the range of light absorption
by IOLs. The rationale was that UV light-filtering
IOLs cannot offer protection to the retina from
phototoxic damage induced by the high-energy,
short-wavelength blue light (400–480 nm), which
is considered to contribute to the pathogenesis
of age-related macular degeneration (AMD).[7, 8]
In response to this potential damage, blue light-
filtering (BLF) IOLs were introduced in 1996 and
have been thereafter widely used, especially in
cataract surgery candidates with signs of AMD
as a possible measure of preventing associated
retinal pathology.[3, 9–12] The yellow tint of BLF IOLs
replicates the spectral transmission properties of
the aged human crystalline lens in a much closer
manner than the UV light-filtering IOLs do.[13]
While the possible visual benefits of BLF IOLs
are still under debate, controversy has been raised
whether a yellow-tinted IOL could modify the visual
performance of patients, specifically regarding the
postoperative best-corrected visual acuity (BCVA),
contrast sensitivity, color vision, and glare.
In addition to BLF, another recently
commercialized property of IOLs that has become
increasingly popular is asphericity. Spherical
aberration has a strong influence on image
quality.[14] It is well-established that conventional-
spherical IOLs degrade image quality by increasing
the spherical higher-order aberrations (HOAs), and
several authors have published studies indicating
that aspheric IOLs may improve retinal image
quality and mesopic contrast sensitivity at low
spatial frequencies.[15–21]
However, the combination of BLF and asphericity
in IOLs has not been clearly investigated regarding
their effect on contrast sensitivity, aberrometry, and
quality of vision. The purpose of this prospective
randomized studywas to evaluate the effect of blue
light-filtering and aphericity of IOL on visual quality
by comparing the three different IOL types: one
aspherical IOL with BLF, one aspherical IOL without
BLF, and one spherical IOL without BLF.
METHODS
This prospective, randomized clinical study
comprised patients who underwent bilateral
cataract surgery for visually significant cataract.
Sixty patients were randomly assigned to receive
one of the three IOL types. Group A received
Bioline Yellow Accurate IOL (aspheric with BLF,
i-medical, Germany), Group B had H65C/N IOL
(aspheric without BLF, PhysIOL, Belgium), and
Group C had BioAcryl60125 IOL (spherical, without
BLF). Each IOL was implanted in 40 eyes of 20
randomly selected patients. All patients were
recruited from the outpatient anterior segment unit
of the Clinic Pallas Ophthalmology Department
in Olten, Switzerland. The study was performed
in adherence with the Declaration of Helsinki for
research involving human subjects after approval
was obtained from the Institutional Review Boards
of Pallas Clinic.
Patients with bilateral cataract with visual
disturbance and no history of color vision
deficiency were eligible for inclusion in the
study. The exclusion criteria were ocular
diseases such as corneal opacity or irregularity,
astigmatism greater than 2.5 D, dry eye syndrome,
inadequate visualization of the fundus, amblyopia,
anisometropia, calculated IOL power less than
10.0 diopters (D) or more than 30.0 D, surgical
complications, IOL tilt, previous or current use
of medications known to cause color vision
deficiencies, and incomplete follow-up. Also,
patients with a history of uveitis and current
intraocular inflammation, uncontrollable glaucoma,
proliferative diabetic retinopathy, or retinal
detachment were excluded from the study.
One experienced surgeon (GP) performed
all surgeries with standard small incision
phacoemulsification and IOL implantation in the
capsular bag. The time between first eye surgery
and second eye surgery was six–eight days in
all cases. All eyes were targeted for emmetropia.
Table 1 shows the characteristics of the IOLs
implanted during the study period. All patients
were given combined antibiotic–steroid eye drops
for four weeks postoperatively. Patients were
examined before surgery and one, seven, and one
to three months postoperatively. At all visits, the
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best corrected-distance visual acuity (BCDVA) and
uncorrected distance visual acuity (UDVA) were
measured. Contrast sensitivity assessment and
aberrometry by means of wavefront analysis were
evaluated at the baseline (preoperatively) and last
follow-up visit which was performed one to three
months postoperatively.
Visual acuity was measured using Snellen
chart under scotopic conditions (target luminance
1.5 candelas [cd]/m2). Contrast sensitivity was
assessed using Functional Acuity Contrast Testing
(FACT-Optec6500, Stereo Optical Inc., USA) with
spectacle correction under photopic conditions
(target luminance value 85 candelas [cd]/m2) and
mesopic conditions (target luminance value 3
cd/m2) with and without glare. Lighting conditions
were controlled with a luxometer (Gossen-Starlite).
The log base 10 contrast sensitivity values were
used to construct a graph for each spatial
frequency tested and then presented using the
original test scale.
A Zywave Hartmann-Shack aberrometer
(Bausch & Lomb, Germany) was used for all
aberrometry measurements. Zywave was used
to assess and compensate for the refractive
errors, and, eye fogging system was acquired
before each wavefront measurement to avoid
patient accommodation. Before use, the
aberrometer was calibrated by an experienced
Bausch & Lomb technician to ensure the
accuracy. Five measurements were performed
by a single experienced technician to avoid
interobserver variability in the results; of these,
two measurements with higher deviations from
the mean were excluded and the three best
measurements were averaged and used for
statistical analyses. Patients were instructed to
blink between measurements, and acquisition was
obtained after a blink to ensure higher quality
results by limiting tear film disruption. All results
were exported as raw data so that individual
Zernike terms could be analyzed independently.
The details of the Zernike coefficients up to
the third order were recorded and used for the
statistical analysis. Zywave measurements were
obtained without any pharmacologic mydriasis and
dark adaptation. Nonetheless, all measurements
were made in certain mesopic lighting conditions
and it was confirmed that pupillary diameter was
at least 6 mm in every case. Total, corneal, and
internal components for each of the high-order
aberrations were obtained and used for the
analysis.
Statistical analysis was performed using the
SPSS (version 17.0 for Windows, SPSS, Inc.
Chicago, IL) and MedCalc statistical software
(version 9.3.0.0, MariaKerke, Belgium). Normality
was checked using the Kolmogorov–Smirnov
test. Since data were not normally distributed
in all cases, both parametric and nonparametric
methods were used. For normally distributed data,
Pearson correlation was used to evaluate the
association between two continuous variables and
the one-way analysis of variance (ANOVA) was
applied to evaluate the influence of a qualitative
factor on another continuous variable. The
association of not normally distributed data
was assessed using Rank correlation calculating
Spearman’s coefficient rho. When parametric
analysis was possible, the Student’s t-test was
used to compare the outcomes between two IOL
groups. Categorical variables were compared
using the Fisher’s exact test. Nonparametric
Kruskal–Wallis and Mann–Whitney tests were
also used to examine the associations between
categorical variables and continuous or ordered
outcomes. A P-value of < 0.05 was defined for all
statistical tests as statistically significant.
RESULTS
A total number of 120 eyes of 60 patients (mean
age, 72.4 ± 9.5 years) who underwent uneventful
bilateral cataract surgery were found eligible and
were finally enrolled in the statistical analysis. All
eyes were divided into one of the three groups,
based on the type of IOL they received. The main
demographic and clinical characteristics of each
group are demonstrated in Table 2.
There were no statistically significant differences
among the study groups in preoperative clinical
and refractive values. Preoperative total and
internal components of aberrometry showed great
deviations between cases, as patients with various
degrees and types of cataracts were included.
However, the preoperative corneal component
of coma, defocus, and trefoil did not have any
statistically significant difference among the three
groups (P > 0.05). The mean Snellen postoperative
BCVA was 0.95 ± 0.08 (0.023 LogMAR) with a
mean postoperative spherical equivalent of –0.32
± 0.13D; not differing statistically between the IOL
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Table 1. Main characteristics and special features of the intraocular lenses used in the study
Bioline Yellow H65C/N Bioacryl
Optic material Hydrophilic acrylic




Optic design Biconvex aspherical Biconvex aspherical Spherical
Optic diameter (mm) 6.0 6.5 6.0
Length (mm) 12.0 12.5 12.5
Design 360º square edge 360º reinforced edge
design ”pco-barrier”
360º square edge
Haptic angulation (º) 0 5 5
Ultraviolet filter With BLF Without BLF Without BLF
A-constant 118.8 118.9 118.0




BLF, blue light filtering
Table 2. Main demographics and clinical characteristics of the study participants
Bioline Yellow H65C/N Bioacryl 60125 P-value† Total
Gender 21F/19M 22/18M 19F/21M 0.79 62F/58M
Age (years) 70.3 ± 8.7 74.6 ± 8.3 72.5 ± 6.4 0.53 72.4 ± 9.5
Axial length (mm) 24.1 ± 1.7 23.6 ± 2.2 23.7 ± 1.6 0.59 23.8 ± 2.1
Preoperative SE 0.19 ± 1.4 0.45 ± 1.5 0.39 ± 1.2 0.68 0.34 ± 1.5
Postoperative SE –0.32 ± 0.2 –0.34 ± 0.2 –0.31 ± 0.2 0.41 –0.32 ± 0.4
IOL power 21.1 ± 2.9 22.5 ± 1.4 22.2 ± 2.6 0.15 21.8 ± 2.5
BCVA preop,
LogMAR (Decimal)
0.38 (0.42 ± 0.16) 0.29 (0.53 ± 0.12) 0.32 (0.48 ± 0.18) 0.59 0.33 (0.47 ± 0.17)
BCVA postop,
LogMAR (Decimal)
0.018 (0.96 ± 0.07) 0.031 (0.93 ± 0.09) 0.022 (0.95 ± 0.08) 0.59 0.023 (0.948 ± 0.08)
CR preop 7.65 ± 0.3 7.64 ± 0.3 7.66 ± 0.2 0.87 7.65 ± 0.3
CR postop 7.66 ± 0.3 7.66 ± 0.3 7.69 ± 0.2 0.93 7.67 ± 0.3
†P-value (significance level) was calculated by means of chi-square test, ANOVA-test and Kruskal–Wallis test.
SE, spherical equivalent; BCVA, best-corrected visual acuity; CR, corneal radius LogMAR, logarithm of the minimum angle of
resolution
groups (Table 2; P > 0.05). The mean LogMAR
uncorrectedVA (UCVA) increased from0.58±0.25
(Bioline Yellow), 0.54 ± 0.23 (H65C/N), and 0.55 ±
0.26 at screening to 0.23 ± 0.12, 0.22 ± 0.11, and
0.24 ± 0.11, respectively, at postoperative follow-
up. There was no statistically significant difference
in the postoperative UCVA among the IOL groups.
Postoperative values were recorded at amean time
of 63.2 ±11.7 days after uneventful cataract surgery
varying between 38 and 87 days, with no significant
difference among the groups in the duration of
follow-up (ANOVA, P = 0.21). Table 2 demonstrates
the preoperative and postoperative refraction data
in more details.
Mean defocus and coma values did not
yield any statistically significant difference
among IOL groups varying from –0.784
to –0.614 and 0.129 to 0.198, respectively
(Table 3). Bioline Yellow Accurate presented
less trefoil aberrations, 0.108 ± 0.05 μm
compared to the other two IOL types (P <
0.05). Table 3 illustrates the second- and third-
order aberrations as well as their intergroup
comparisons.
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Table 3. Comparisons of second- and third-order aberrations among the three IOL groups
IOL (Group) Defocus (Z200) Coma (Z311, Z310) Trefoil (Z331, Z330)
Bioline Yellow (Group1) –0.7842 ± 0.9915 0.1288 ± 0.1075 0.1082 ± 0.049
PhysIOL H65C/N (Group2) –0.6557 ± 0.7235 0.1573 ± 0.1186 0.1929 ± 0.1736
BioAcryl 60125 (Group3) –0.6136 ± 0.6239 0.1984 ± 0.1599 0.2058 ± 0.1852
Mean –0.69 ± 0.72 0.16 ± 0.13 0.16 ± 0.15
Comparison between
groups (P-value)
Group1–Group2 0.52 0.11 0.03
Group1–Group3 0.59 0.43 0.042
Group2–Group3 0.8 0.36 0.82
Table 4. Mean loss of contrast sensitivity, expressed in logarithmic units, from photopic to mesopic lighting conditions (LC) and
under glare conditions in mesopic LC.
Loss Photopic to Mesopic LC Loss Mesopic to Mesopic with glare LC
Spatial Frequency (cpd) 1.5 3 6 12 18 1.5 3 6 12 18
IOL1 0.051 0.105 0.227 0.406 0.569 0.096 0.23 0.233 0.452 0.256
IOL2 0.021 0.129 0.185 0.400 0.358 0.165 0.121 0.154 0.217 0.331
IOL3 0.030 0.140 0.221 0.521 0.433 0.167 0.139 0.229 0.099 0.206
P(ANOVA)† 0.69 0.62 0.69 0.69 0.27 0.17 0.04 0.75 0.02 0.64
P(t-test)1–2* 0.43 0.59 0.17 0.77 0.25 0.13 0.01 0.71 0.27 0.84
P(t-test)1–3* 0.53 0.31 0.60 0.34 0.41 0.20 0.05 0.84 0.04 0.81
P(t-test)2–3* 0.92 0.64 0.60 0.62 0.75 0.98 0.77 0.85 0.30 0.67
IOL1, Bioline Yellow Accurate; IOL2, Physiol H65C/N; IOL3, BioAcryl60125; cpd, cycles per degree
†P-value comparing all three IOL groups with one-way analysis of variance; *P-value comparing IOL groups in couples with
Student’s t-test
There was no statistically significant difference
among the three IOL groups in contrast sensitivity
at any spatial frequency under all three lighting
conditions. Figure 1 (photopic 85 cd/m2), Figure
2 (mesopic 3 cd/m2), and Figure 3 (mesopic with
glare) depict postoperative contrast sensitivity for
all IOL groups. In a separate analysis, Bioline Yellow
was found to have a statistically lower contrast
sensitivity under glare conditions compared to the
BioAcryl and PhysIOL in 12 and 3 cpd spatial
frequencies, respectively (P < 0.05). Table 4
compares the postoperative contrast sensitivity
among the IOL groups.
DISCUSSION
Modern cataract surgery with the implementation
of specially designed IOLs has developed
tremendously over the past decades, attempting
to meet patients’ expectations for optimal visual
outcomes.[11, 19, 21] Contemporary diagnostic
tools have extended our knowledge on the
impact of HOAs and contrast sensitivity
on the quality of vision. Therefore, in
order to achieve the best outcome after
phacoemulsification, the IOL implantation should
result in minimal aberrations and high-contrast
sensitivity.
IOLs with aspheric optics, designed to optimize
postoperative spherical aberration and implants
with BLF as a possible measure of preventing
associated retinal pathology have gained
great popularity. However, there is still great
controversy on their potential benefit and the
effect of these features on the postoperative
visual performance, specifically regarding the
ultimate BCVA, contrast sensitivity, color vision,
and postoperative aberrations.[1–5, 9–12, 15–21]
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Figure 1. Postoperative contrast sensitivity (log) under photopic conditions (85 cd/m2) in various spatial frequencies for the IOLs
included in the study [IOL1 = Bioline Yellow Accurate (i-medical, Germany), IOL2 = BioAcryl 60125 (Biotech, France), IOL3 = H65C/N
(PhysIOL, Belgium)].
The present prospective randomized study
attempted to investigate the effect of BLF
and aspherical IOL design on the final visual
outcome. Therefore, we compared the visual
performance after the implantation of three
different IOLs; one aspheric, with BLF; one
aspheric, without BLF; and one spherical, without
BLF. Our results showed that BCVA did not
differ statistically significantly among the IOL
groups. These results regarding the effect of
BLF in postoperative BCVA are in concordance
with a recent Cochrane Database Systematic
Review which demonstrated, with moderate
certainty, that the presence of BLF in IOLs had
no clinically meaningful effect on short-term
BCVA.[22]
Although no significant difference was found
in our study among the different IOL groups in
the postoperative BCVA, the group of patients
implanted with an aspheric IOL with BLF indicated
fewer trefoil aberrations when compared to the
other IOL groups included in the study. Notably,
the preoperative corneal component of HOAs did
not differ significantly among the three IOL groups.
Therefore, the lower trefoil measurements shown
in this group could be attributed to the internal
components, mainly the IOL itself. A postoperative
IOL tilt could also be a predisposing factor for
increased aberrations.
Blue-light filtering is an add-on feature of
IOLs, considered to offer an extra retinal
protection against AMD, although this has not
been fully proven so far.[23] IOLs with BLF are
supposed to reduce longitudinal chromatic
aberrations. Theoretically, such a reduction
should not affect spherical aberrations. However,
in our study, the yellow-tinted IOL achieved
better results in postoperative trefoil when
compared not only to the spherical IOL but
also to the aspheric one without BLF. It should
be noticed that the two aspheric IOLs used in
this study had minimal differences in terms of
optical design and material being produced by
different manufacturers. This fact could also
have some impact on the results reported.
To the best of our knowledge, there are no
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Figure 2. Postoperative contrast sensitivity (log) under mesopic conditions (3 cd/m2) in various spatial frequencies for the IOLs
included in the study [IOL1 = Bioline Yellow Accurate (i-medical, Germany), IOL2 = BioAcryl 60125 (Biotech, France), IOL3 = H65C/N
(PhysIOL, Belgium)].
published studies evaluating the effect of BLF
on spherical HOAs by comparing the same IOL
types.
As far as postoperative contrast sensitivity is
concerned, no significant difference was found
among IOLs in any spatial frequency under
photopic, mesopic, and mesopic with glare-lighting
conditions. However, the yellow-tinted aspheric
IOL was found to have a statistically higher
loss of contrast sensitivity under glare conditions
compared to the non-tinted IOLs at some spatial
frequencies.
In recent years, aspheric IOLs have gained
increasing popularity among surgeons due to their
theoretical advantage of being able to compensate
for the spherical aberration of the human cornea,
with the aim of restoring the optical performance
of the eye.[14] Most studies performed on this
task have confirmed this theory reporting that
aspheric IOLs implanted have significantly reduced
the overall spherical aberrations, hence improving
optical performance in certain cases.[15, 17–24]
Comparing the aspheric Tecnis ZA9003 IOL
with the spherical AcrySof SA60AT IOL (Alcon, Inc.),
Kim et al[25] reported a significant improvement in
contrast sensitivity under mesopic and photopic
conditions with the aspheric IOL; the authors
reported that the mean spherical aberration
was significantly higher in eyes implanted with
the spherical IOL, although total higher order
aberrations did not differ significantly between
the results of two further prospective randomized
studies performed by Rocha et al and Caporrosi
et al, who concluded that eyes implanted with
aspheric IOLs had less aberrations and performed
better under mesopic condition compared to
spherical IOLs.[18, 26]
On the contrary, several researchers have
reported no statistically significant differences
in visual acuity and contrast sensitivity between
spherical IOLs and aspheric IOLs.[27–29] We
compared in our study the outcome of the three
different IOLs, two aspheric and one spherical
and found no statistically significant difference
in the second- and third-order aberrations other
314 JOURNAL OF OPHTHALMIC AND VISION RESEARCH VOLUME 15, ISSUE 3, JULY-SEPTEMBER 2020
Aspheric and Blue Light Filtering IOLs; Tzamalis et al
Figure 3. Postoperative contrast sensitivity (log) under mesopic with glare conditions (3 cd/m2 with glare) in various spatial
frequencies for the IOLs included in the study [IOL1 = Bioline Yellow Accurate (i-medical, Germany), IOL2 = BioAcryl 60125 (Biotech,
France), IOL3 = H65C/N (PhysIOL, Belgium)].
than trefoil aberrations that was lower in the
eyes implanted with aspheric IOL with a BLF.
Surprisingly, no difference was noted between
the two non-tinted IOL groups, despite one of
them having an aspherical design. One may
hypothesize that BLF added on yellow-tinted
IOLs could reduce some spherical aberrations
along with the longitudinal chromatic ones;
however, this theory needs to be examined by
further prospective randomized studies with larger
population sizes to compare aberrations between
IOLs of identical design and material.
In the past decade, several manufacturers and
distributors have promoted commercially available
IOLs with BLF properties. Theoretically, BLF IOLs
may induce a reduction in mesopic and scotopic
visual performance attributed to the Purkinje shift,
where differing peaks of spectral sensitivity for
scotopic and photopic vision are identified.[1, 3]
Violet and blue lights are much more important
for vision in dim-light environments than in bright-
light environments, providing 45% of rod-mediated
aphakic scotopic sensitivity but only 7% of photopic
sensitivity for an iso-illuminance light source.[1, 2]
However, the results reported in the literature
are controversial regarding postoperative contrast
sensitivity after the BLF-IOL implantation and do
not indicate a significant decrease in the mesopic
and scotopic visual function.
Kara-Junior et al[30] investigated the long-term
possible side effects after implantation of an IOL
with a BLF. The authors found no significant
differences in color perception, scotopic contrast
sensitivity, or photopic contrast sensitivity between
the BLF IOL and the IOL with a UV-light filter only.
In another study, Greenstein et al[31] investigated
contrast sensitivity in nine patients implanted
with a BLF IOL (AcrySof SN60AT) in one eye
and a UV-only filtering IOL (AcrySof SA60AT) in
the fellow eye. In addition, they compared the
results with those obtained in nine young phakic
patients and found no significant difference in hue
discrimination or dark-adapted sensitivity between
the two IOLs.[31] These results were comparable
to the outcome of a study by Muftuoglu et al[32]
who compared photopic and scotopic CS in eyes
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with an AcrySof SN60AT IOL (with BLF) and
eyes with a conventional AcrySof SA60AT IOL
(UV-only filtering) and reported no statistically
significant differences between the two IOL types.
Furthermore, Hayashi et al[9] measured contrast
visual acuity in 74 patients implanted bilaterally with
either tinted IOL (HOYAYA60BB) or non-tinted IOLs
(VA60BB) and reported no significant difference
between the IOL groups.
In concordance with these aforementioned
studies, our results showed no statistically
significant difference in contrast sensitivity
between IOLs with and without BLF. In an
additional analysis, we evaluated the loss of
contrast sensitivity after glare was applied in
mesopic conditions and found that the tinted IOL
had a statistically greater loss of contrast sensitivity
under glare compared to the non-tinted IOLs, but
only in some spatial frequencies. Although this may
be an accidental finding, it is noteworthy as most
previous studies did not include contrast sensitivity
measurement in mesopic conditions under glare,
a situation that is rather common in real life, such
as night driving, and can substantially affect the
patient’s quality of life after cataract surgery.
A weakness worth mentioning of all studies
reporting mesopic CS results after the implantation
of IOLs with BLF is the fact that all have utilized
measures that are a function of only central vision,
where macular pigment is also acting as a BLF.
Moreover, one should consider that mesopic vision
is mediated, at least in part, by cones, and therefore
it is less likely to be adversely influenced by
the transmittance properties of such blue-blocking
IOLs. Other limitations of our study include the
relatively small sample size and the lack of a group
with implantation of a spherical IOL with BLF; this
type of IOL was not commercially available at the
time the study was conducted.
In summary, the present study compared three
IOLs varying in terms of asphericity and BLF and
showed only minimal differences in postoperative
contrast sensitivity and aberrometry. All IOLs
achieved comparable results in postoperative
visual performance; an aspheric IOL with BLF,
however, resulted in less trefoil aberrations and
a greater loss of contrast sensitivity in mesopic
conditions when glare was applied. Further
randomized patient-centered studies are needed
to evaluate the long-term results of aspheric IOL
design and BLF and to investigate whether these
features are desirable for the patients’ quality of
life.
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